Introduction:

Cholesterol Testing Services Market was valued at US$ 26.4 billion in 2024 and is projected to grow at a CAGR of 12.3% to reach US$ 84.4 Billion by 2034.

Cholesterol is a waxy substance present in our blood. It is an essential chemical compound required for synthesis of cell membranes and hormones such as estrogen and testosterone. Cholesterol is produced by liver and it is also provided by dietary sources such as meat, poultry, eggs, fish, and dairy products. It is absorbed by the small intestine and metabolized and stored in the liver. Excessive intake of cholesterol can lead to its deposition on walls of arteries narrowing their diameter, which can lead to various cardiovascular disorders. Many different factors can lead to high blood cholesterol, including lifestyle factors such as smoking, eating junk food, lack of exercise as well as having high blood pressure or diabetes.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Drivers: Excess fat levels and cholesterol levels

Changes in eating habits of people had led to increase in the number of people suffering from obesity and fluctuation in their cholesterol levels is the major factor driving the growth of the cholesterol testing services market. Furthermore, constantly growing geriatric population with high concentration of cholesterol in plasma is driving growth of the market. Moreover, increasing inclination of population towards smoking and alcohol consumption can result into high cholesterol deposition, which in turn is propelling demand for its diagnostic tests. Approval of home cholesterol tests by the U.S Food and Drug Administration (FDA) to measure total fat levels in blood with 95% accuracy is also expected to boost growth of the market.

Restraints: Lack of diagnostics laboratories

However, lack of diagnostic laboratories and skilled pathological professionals in emerging economies are restraining growth of the market.

The cholesterol testing services market is segmented based on age group, service provider, and region.

On the basis of age group, the global cholesterol testing services market is segmented into geriatric, adults, and pediatric. Based on the service provider, the target market is segmented into hospitals, diagnostic laboratories, ambulatory care centers, and others.

Regional Insights:

The cholesterol testing services market accounted for US$ 16.22 billion in 2020 and is estimated to be US$ 35.66 billion by 2030 and is anticipated to register a CAGR of 12.2%. On region the global cholesterol testing services market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America dominates the cell culture market owing to increasing presence of biopharmaceutical industries with increasing demand of precision medicine. Asia is projected to be the fastest-growing region in terms of CAGR during the forecast period. This is due to the large population base, increased prevalence of cardiovascular diseases, and growing number of testing facilities in the Asian region.

Report Scope:

Attribute	Details
Market Size 2024	US$ 26.4 billion
Projected Market Size 2034	US$ 84.4 billion
CAGR Growth Rate	12.30%
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	By Age Group- Geriatric, Adults, and Pediatric By Service Provider– Hospitals, Diagnostic Laboratories, Ambulatory Care Centers, and Others
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global cholesterol testing services market report based on age group, service provider, and region.

Cholesterol Testing Services Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The key players operating in the cholesterol testing services market include Quest Diagnostics Incorporated, Spectra Laboratories Inc., Bio-Reference Laboratories Inc., Eurofins Scientific (Luxembourg), Clinical Reference Laboratory, Inc. (CRL), ACM Medical Laboratory, Adicon Clinical Laboratory, Unilabs, SYNLAB International GmbH, and Laboratory Corporation of America Holdings (LabCorp).

• Quest Diagnostics Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Spectra Laboratories Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Bio-Reference Laboratories Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Eurofins Scientific
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Clinical Reference Laboratory Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• ACM Medical Laboratory
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Adicon Clinical Laboratory
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Unilabs
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• SYNLAB International GmbH
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Laboratory Corporation of America Holdings
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

 “*” marked represents similar segmentation in other categories in the respective section

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
   • PORTER’s
   • Investment Outlook
3. Market Purview
   • Executive Summary
   • Key Findings—Global Outlook for Cholesterol Testing Services Strategies
     • Key Questions this Study will Answer

     • •  By Age Group (Geriatric, Adults, and Pediatric),

       • By Service Provider (Hospitals, Diagnostic Laboratories, Ambulatory Care Centers, and Others) 

       • By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Overview
   • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2024 – 2034
   • Y-o-Y Growth Analysis (%), 2024 – 2034
   • Regional Trends
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Regional Analysis
   • Regional Revenue Analysis
   • Regional By segment Analysis
   • Reasons for regional growth
   • Key Player of particular region
   • Countries Include in the report:

1. • • North America (U.S., Canada)
     • Europe (UK, France, Germany, Russia, Italy, Rest of Europe)
     • Asia Pacific (India, Japan, South Korea, China, Rest of Asia Pacific)
     • Latin America (Brazil, Mexico, Rest of Latin America)
     • Middle East & Africa (GCC, Israel, South Africa, Rest of Middle East)

1. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
   • Competitive Overview
   • Competitive Benchmarking
   • Market Share Analysis
   • Key Developments In The Global Cholesterol Testing Services Market
   • Key Developments: Mergers & Acquisitions
   • Key Developments: Collaboration
   • Key Developments: Contracts & Agreements
   • Key Developments: Expansion
   • Key Developments: Product Developments
2. Company Profiles

 

• Company Overview
• Product Portfolio
• Key Highlights
• Financial Performance
• Business Strategies
• SWOT Analysis

• Quest Diagnostics Incorporated, Spectra Laboratories Inc., Bio-Reference Laboratories Inc., Eurofins Scientific (Luxembourg), Clinical Reference Laboratory, Inc. (CRL), ACM Medical Laboratory, Adicon Clinical Laboratory, Unilabs, SYNLAB International GmbH, and Laboratory Corporation of America Holdings (LabCorp).

1. The Last Word
   • Future Impact
   • About Us
   • Contact